HU9600471D0 - Iontophoretic delivery of an antimigraine drug - Google Patents

Iontophoretic delivery of an antimigraine drug

Info

Publication number
HU9600471D0
HU9600471D0 HU9600471A HU9600471A HU9600471D0 HU 9600471 D0 HU9600471 D0 HU 9600471D0 HU 9600471 A HU9600471 A HU 9600471A HU 9600471 A HU9600471 A HU 9600471A HU 9600471 D0 HU9600471 D0 HU 9600471D0
Authority
HU
Hungary
Prior art keywords
formula
6alkyl
hydrogen
pct
bivalent
Prior art date
Application number
HU9600471A
Other languages
Hungarian (hu)
Other versions
HUT75062A (en
Inventor
Beukelaar Frank Maria Jozef De
Jean Louis Mesens
Reet Gustaaf Van
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HU9600471D0 publication Critical patent/HU9600471D0/en
Publication of HUT75062A publication Critical patent/HUT75062A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PCT No. PCT/EP94/02764 Sec. 371 Date Jan. 26, 1996 Sec. 102(e) Date Jan. 26, 1996 PCT Filed Aug. 19, 1994 PCT Pub. No. WO95/05815 PCT Pub. Date Mar. 2, 1995The present invention relates to the iontophoretic delivery to a patient, more in particular to a migraine patient, of a compound of formula (I) as shown hereinunder. The invention also relates to a device for the iontophoretic delivery of a compound of formula (I), as well as to a composition containing a compound of formula (I), which can be applied in a device for iontophoretic delivery. Said compounds are benzopyranalkylaminoalkyl substituted guanidines having the formula <IMAGE> (I) the pharmaceutically acceptable acid addition salts thereof, and the stereochemically isomeric forms thereof, wherein R1 is hydrogen or C1-6alkyl; R2 is hydrogen, C1-6alkyl, C3-6alkenyl or C3-6alkynyl; R3 is hydrogen or C1-6alkyl; or R2 and R3 taken together form a bivalent radical of formula -(CH2)m- wherein m is 4 or 5; or R1 and R2 taken together form a bivalent radical of formula -CH=CH- or of formula -(CH2)n-, wherein n is 2, 3 or 4; or R3 may represent a bond when R1 and R2 taken together form a bivalent radical of formula -CH=CH-CH=; R4 and R5 each independently are hydrogen or C1-6alkyl; Alk1 is a bivalent C1-3alkanediyl radical; Alk2 is a bivalent C2-15alkanediyl radical; and R6 and R7 each independently are hydrogen, halo, C1-6alkyl, C3-6alkenyl, C3-6alkynyl, hydroxy, C1-6alkyloxy or cyano.
HU9600471A 1993-08-27 1994-08-19 Antimigraine pharmaceutical preparation, and delivery for iontophoretic treatment HUT75062A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93202523 1993-08-27

Publications (2)

Publication Number Publication Date
HU9600471D0 true HU9600471D0 (en) 1996-04-29
HUT75062A HUT75062A (en) 1997-03-28

Family

ID=8214068

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9600471A HUT75062A (en) 1993-08-27 1994-08-19 Antimigraine pharmaceutical preparation, and delivery for iontophoretic treatment

Country Status (28)

Country Link
US (1) US5674871A (en)
EP (1) EP0719138B1 (en)
JP (1) JP2921987B2 (en)
KR (1) KR100187632B1 (en)
CN (1) CN1096857C (en)
AT (1) ATE176591T1 (en)
AU (1) AU687876B2 (en)
BR (1) BR9407522A (en)
CA (1) CA2168449A1 (en)
CZ (1) CZ290473B6 (en)
DE (1) DE69416522T2 (en)
DK (1) DK0719138T3 (en)
ES (1) ES2129668T3 (en)
FI (1) FI960887A (en)
GR (1) GR3029920T3 (en)
HR (1) HRP940481A2 (en)
HU (1) HUT75062A (en)
IL (1) IL110784A (en)
MY (1) MY111022A (en)
NO (1) NO317628B1 (en)
NZ (1) NZ273304A (en)
PH (1) PH31437A (en)
PL (1) PL176290B1 (en)
RU (1) RU2166315C2 (en)
SG (1) SG50469A1 (en)
SI (1) SI9400333B (en)
WO (1) WO1995005815A1 (en)
ZA (1) ZA946533B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853383A (en) * 1995-05-03 1998-12-29 Alza Corporation Preparation for formulations for electrotransport drug delivery
US7137975B2 (en) * 2001-02-13 2006-11-21 Aciont, Inc. Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent
CN100379473C (en) * 2001-04-04 2008-04-09 阿尔扎公司 Transdermal electrotransport delivery device including antimicrobial compatible reservoir composition
WO2002089803A1 (en) * 2001-05-07 2002-11-14 Sankyo Company, Limited Composition for iontophoresis
US8016811B2 (en) * 2003-10-24 2011-09-13 Altea Therapeutics Corporation Method for transdermal delivery of permeant substances
US20050220439A1 (en) * 2004-03-19 2005-10-06 Carton Owen A Interactive multimedia system and method
WO2007009462A2 (en) * 2005-07-15 2007-01-25 Region Hovedstaden V/Glostrup Hospital Treatment of migraine and headaches
AU2007238685B2 (en) * 2006-04-13 2012-09-13 Teva Pharmaceuticals International Gmbh Transdermal methods and systems for the delivery of anti-migraine compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015260A1 (en) * 1990-03-30 1991-10-17 Alza Corporation Device and method for iontophoretic drug delivery
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines

Also Published As

Publication number Publication date
NZ273304A (en) 1997-02-24
HUT75062A (en) 1997-03-28
WO1995005815A1 (en) 1995-03-02
NO960769L (en) 1996-04-23
JPH09501180A (en) 1997-02-04
ES2129668T3 (en) 1999-06-16
CZ57096A3 (en) 1996-08-14
IL110784A0 (en) 1994-11-11
RU2166315C2 (en) 2001-05-10
EP0719138A1 (en) 1996-07-03
HRP940481A2 (en) 1997-08-31
DE69416522D1 (en) 1999-03-25
CN1096857C (en) 2002-12-25
AU7654294A (en) 1995-03-21
CA2168449A1 (en) 1995-03-02
FI960887A0 (en) 1996-02-26
ATE176591T1 (en) 1999-02-15
PL313255A1 (en) 1996-06-24
SG50469A1 (en) 1998-07-20
PL176290B1 (en) 1999-05-31
FI960887A (en) 1996-02-26
MY111022A (en) 1999-07-31
NO317628B1 (en) 2004-11-29
NO960769D0 (en) 1996-02-26
US5674871A (en) 1997-10-07
JP2921987B2 (en) 1999-07-19
CZ290473B6 (en) 2002-07-17
AU687876B2 (en) 1998-03-05
BR9407522A (en) 1997-01-07
GR3029920T3 (en) 1999-07-30
PH31437A (en) 1998-11-03
KR100187632B1 (en) 1999-06-01
SI9400333A (en) 1995-04-30
EP0719138B1 (en) 1999-02-10
IL110784A (en) 1999-05-09
SI9400333B (en) 2002-02-28
DK0719138T3 (en) 1999-09-20
DE69416522T2 (en) 1999-09-23
CN1129905A (en) 1996-08-28
ZA946533B (en) 1996-02-26

Similar Documents

Publication Publication Date Title
NO960648D0 (en) Vasoconstrictively substituted aryloxyalkyl diamines
MY117852A (en) Alkylaminobenzothiazole and- benzoxazole derivatives
ZA946533B (en) Iontophoretic delivery of an antimigraine drug
BG99593A (en) Application of dtmethylbenzofurans as 5-ht3 antagonists
ES2132424T3 (en) DIHYDROPYRAN PIRIDINES SUBSTITUTED AS VASOCONSTRICTORS.

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees